Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07383961 · ClinicalTrials.gov registry record
Long Term Follow UP After Pediatric Single Site Robotic Cholecystectomy
A clinical trial, sponsored by Good Samaritan Hospital Medical Center, New York.
- Completed
- Registry status
- 150
- Enrollment target
NCT07383961: Completed study, sponsored by Good Samaritan Hospital Medical Center, New York.
NCT07383961 is a clinical trial that has completed, run by Good Samaritan Hospital Medical Center, New York. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07383961 has completed, sponsored by Good Samaritan Hospital Medical Center, New York.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Robotic single-site cholecystectomy (RSSC) was first reported in children the PI from GSH in 2015, demonstrating the feasibility, safety, and short learning curve associated with RSSC. The primary advantages of RSSC identified in pediatric patients include superior cosmetic outcomes, reduced postoperative pain, and a shorter learning curve for surgeons compared to SILC. These benefits contribute to its growing acceptance among pediatric surgeons. However, despite clear short-term benefits, the need for evaluating long-term outcomes in pediatric populations remains unmet. There are currently no studies reporting long-term complications or cosmetic satisfaction following RSSC in pediatric patients. This study will attempt to evaluate the long term outcomes after RSSC and compare them with the current gold standard, multiport laparoscopic cholecystectomy, performed by the same surgeon at the same institution over a similar time frame.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2025-12-31 |
What the finished NCT07383961 record still lists
NCT07383961 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07383961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07383961 about?
NCT07383961 is a clinical study titled "Long Term Follow UP After Pediatric Single Site Robotic Cholecystectomy". Robotic single-site cholecystectomy (RSSC) was first reported in children the PI from GSH in 2015, demonstrating the feasibility, safety, and short learning curve associated with RSSC. The primary advantages of RSSC identified in pediatric patients include superior cosmetic outcomes, reduced postop...
What is the current status of trial NCT07383961?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2025-08-01. Estimated completion is 2025-12-31.
Who is sponsoring clinical trial NCT07383961?
This trial is sponsored by Good Samaritan Hospital Medical Center, New York, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI